Skip to main content

Biomea Fusion, Inc.

BMEA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001840439

No open-market purchases or sales by Biomea Fusion, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Biomea Fusion, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of BMEA: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders9085−5
Shares29.6M30.1M+538.0K (+1.8%)
Value$649.4M$414.5M−$234.9M (−36.2%)

New holders (12)

Institutions that held Biomea Fusion, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to BMEA in Q3 2023
InstitutionSharesValue% of portfolio
Two Sigma Advisers, LP306,800$4.22M0.01%
Prosight Management, LP94,817$1.30M0.41%
Cubist Systematic Strategies, LLC91,595$1.26M0.02%
Squarepoint Ops LLC44,061$606.3K0.00%
Trexquant Investment LP31,573$434.4K0.01%
E Fund Management Co., Ltd.12,010$165.0K0.01%
UBS Asset Management Americas Inc11,600$159.6K0.00%
Corton Capital Inc.11,064$152.2K0.08%
Sandia Investment Management LP6,200$85.3K0.02%
Simplex Trading, LLC6,001$82.0K0.00%
Allspring Global Investments Holdings, LLC1,133$15.6K0.00%
Group One Trading, L.P.129$1.77K0.00%

Sold out (17)

Institutions that held Biomea Fusion, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.